• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清载脂蛋白A-I与声带息肉形成的相关性

Correlations Between Serum Apolipoprotein A-I and Formation of Vocal Cord Polyp.

作者信息

Zhang Hui-Ping, Zhang Rong

机构信息

Department of Otolaryngology and Head-Neck Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.

Department of Otolaryngology and Head-Neck Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.

出版信息

J Voice. 2017 May;31(3):380.e1-380.e6. doi: 10.1016/j.jvoice.2016.05.007. Epub 2016 Nov 2.

DOI:10.1016/j.jvoice.2016.05.007
PMID:27816355
Abstract

OBJECTIVE

This study aims to investigate the correlations between serum apolipoprotein A-I (ApoA-I) and the formation of vocal cord polyps (VCPs).

STUDY DESIGN

This study used the nonmatched case-control study method.

METHODS

The serum total cholesterol (TC), triglyceride, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol, ApoA-I, apolipoprotein B (ApoB), and ApoA-I/ApoB levels of 89 VCP patients and 87 normal volunteers were compared. Additionally, such VCP-related factors as excessive vocal use, vocal abuse, smoking, drinking, and the size of VCPs were analyzed.

RESULTS

The two groups did not significantly differ with regard to triglyceride, low-density lipoprotein cholesterol, ApoB, and ApoA-I/ApoB levels (P > 0.05), whereas they did significantly differ with regard to TC, HDL-C, and ApoA-I levels (P < 0.05) according to independent t tests. Logistic regression analysis showed that excessive vocal use and vocal abuse were risk factors for VCPs (P < 0.05), with odds ratio values of 5.675 and 12.781, respectively. The ApoA-I level was negatively associated with VCPs (P < 0.05), with an odds ratio of 0.511; however, TC and HDL-C were not associated with the formation of VCPs (P > 0.05). The size of VCPs in females was negatively correlated with the serum ApoA-I level (r = -0.349, P = 0.032), whereas that in males was not (P > 0.05).

CONCLUSIONS

As the serum ApoA-I level was negatively correlated with the formation of VCPs, ApoA-I may reduce the risk of VCPs. These findings may facilitate the prevention and treatment of VCPs.

摘要

目的

本研究旨在探讨血清载脂蛋白A-I(ApoA-I)与声带息肉(VCPs)形成之间的相关性。

研究设计

本研究采用非匹配病例对照研究方法。

方法

比较89例VCP患者和87名正常志愿者的血清总胆固醇(TC)、甘油三酯、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇、ApoA-I、载脂蛋白B(ApoB)及ApoA-I/ApoB水平。此外,分析了过度用嗓、用嗓不当、吸烟、饮酒及VCPs大小等与VCP相关的因素。

结果

根据独立样本t检验,两组在甘油三酯、低密度脂蛋白胆固醇、ApoB及ApoA-I/ApoB水平方面差异无统计学意义(P>0.05),而在TC、HDL-C及ApoA-I水平方面差异有统计学意义(P<0.05)。Logistic回归分析显示,过度用嗓和用嗓不当是VCPs的危险因素(P<0.05),比值比分别为5.675和12.781。ApoA-I水平与VCPs呈负相关(P<0.05),比值比为0.511;然而,TC和HDL-C与VCPs的形成无关(P>0.05)。女性VCPs大小与血清ApoA-I水平呈负相关(r=-0.349,P=0.032),而男性则无相关性(P>0.05)。

结论

由于血清ApoA-I水平与VCPs的形成呈负相关,ApoA-I可能降低VCPs的发生风险。这些发现可能有助于VCPs的预防和治疗。

相似文献

1
Correlations Between Serum Apolipoprotein A-I and Formation of Vocal Cord Polyp.血清载脂蛋白A-I与声带息肉形成的相关性
J Voice. 2017 May;31(3):380.e1-380.e6. doi: 10.1016/j.jvoice.2016.05.007. Epub 2016 Nov 2.
2
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.碳水化合物、脂质和载脂蛋白代谢的血液生物标志物与肌萎缩侧索硬化症的风险:对瑞典 AMORIS 队列超过 20 年的随访。
Ann Neurol. 2017 May;81(5):718-728. doi: 10.1002/ana.24936.
3
Associations of apolipoprotein B/apolipoprotein A-I ratio with pre-diabetes and diabetes risks: a cross-sectional study in Chinese adults.载脂蛋白B/载脂蛋白A-I比值与糖尿病前期及糖尿病风险的关联:一项针对中国成年人的横断面研究
BMJ Open. 2017 Jan 20;7(1):e014038. doi: 10.1136/bmjopen-2016-014038.
4
Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.使用总胆固醇/高密度脂蛋白胆固醇比值而非载脂蛋白B/载脂蛋白A-I比值来识别脂蛋白相关血管疾病风险所导致的错误。
J Intern Med. 2006 May;259(5):455-61. doi: 10.1111/j.1365-2796.2006.01649.x.
5
Treatment Efficacy of Voice Therapy for Vocal Fold Polyps and Factors Predictive of Its Efficacy.嗓音治疗对声带息肉的疗效及疗效预测因素
J Voice. 2017 Jan;31(1):120.e9-120.e13. doi: 10.1016/j.jvoice.2016.02.014. Epub 2016 Mar 23.
6
Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.胆固醇酯转移蛋白的常见变异:载脂蛋白 B/载脂蛋白 A-I 比值和总胆固醇/高密度脂蛋白胆固醇比值与首次主要心血管不良事件的关系。
J Clin Lipidol. 2013 Jan-Feb;7(1):56-64. doi: 10.1016/j.jacl.2012.05.003. Epub 2012 May 22.
7
An Analysis of the Effects of Voice Therapy on Patients With Early Vocal Fold Polyps.嗓音疗法对早期声带息肉患者的疗效分析
J Voice. 2016 Nov;30(6):698-704. doi: 10.1016/j.jvoice.2015.08.013. Epub 2015 Sep 26.
8
Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.在常规临床血脂检测前联合使用载脂蛋白B/载脂蛋白A1比值和非高密度脂蛋白胆固醇预测冠心病
Coron Artery Dis. 2014 Aug;25(5):433-8. doi: 10.1097/MCA.0000000000000100.
9
The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.载脂蛋白B/载脂蛋白A-I比值在评估血浆促动脉粥样硬化和抗动脉粥样硬化脂蛋白之间的平衡以及预测冠心病风险方面优于胆固醇比值。
Clin Chem Lab Med. 2004;42(12):1355-63. doi: 10.1515/CCLM.2004.254.
10
The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.血清载脂蛋白A-I、载脂蛋白B与冠状动脉造影疾病严重程度之间的关联。
Singapore Med J. 2009 Jun;50(6):610-3.

引用本文的文献

1
Crossover point and maximal fat oxidation training effects on blood lipid metabolism in young overweight women: a pilot study.交叉点和最大脂肪氧化训练对年轻超重女性血脂代谢的影响:一项初步研究。
Front Physiol. 2023 Jun 16;14:1190109. doi: 10.3389/fphys.2023.1190109. eCollection 2023.